Oritavancin

Chemical formula: C₈₆H₉₇Cl₃N₁₀O₂₆  Molecular mass: 1,793.101 g/mol  PubChem compound: 16136912

Therapeutic indications

Oritavancin is indicated for:

Acute bacterial skin and skin structure infections (ABSSSI)

Population group: only adults (18 years old or older)

Bacterial infection of skin and additionally at least one of
Oritavancin susceptible species
Oritavancin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Oritavancin is contraindicated in the following cases:

Intravenous unfractionated heparin sodium

Heparin

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: ORBACTIV Powder for solution for injection
Summary of Product Characteristics (SPC) 2022: TENKASI Powder for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈